Eli Lilly and Company agreed to plead guilty and pay 1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration. This resolution included a criminal fine of 515 million, the forfeiture of 100 million in assets, and up to 800 million in a civil settlement with the federal government and the states.